上海
分享至
财联社4月7日电，国家药监局药品审评中心（CDE）官网最新公示，诺华（Novartis）申报的英克司兰钠注射液新适应症上市申请获得受理。
特别声明：以上内容(如有图片或视频亦包括在内)为自媒体平台“网易号”用户上传并发布，本平台仅提供信息存储服务。
Notice: The content above (including the pictures and videos if any) is uploaded and posted by a user of NetEase Hao, which is a social media platform and only provides information storage services.
